Table of contents

  • Summary
    • Summary of data against screening pathway
  • 1 Prevention of cervical cancer through organised cervical screening
  • 2 National Cervical Screening Program
  • 3 Performance indicator monitoring
  • 3.1 Recruitment
    • Performance indicator 1: Participation
    • Performance indicator 2: Response to invitation
    • Performance indicator 3: Rescreening
  • 3.2 Screening
    • Performance indicator 4: Screening results
    • Performance indicator 5: Correlation of screening results
    • Performance indicator 6: Screening HPV test positivity
    • Performance indicator 7: Cervical cancer diagnosed after a low risk screening test result
    • Performance indicator 8: Self-collection women positive for oncogenic HPV (not 16/18) who have an LBC test within 6 months
    • Performance indicator 9: Self-collection women positive for oncogenic HPV 16/18 who have a  colposcopy within 6 months
    • Performance indicator 10: Adherence to recommendation for follow-up
    • Performance indicator 11: Follow-up results
  • 3.3 Assessment
    • Performance indicator 12: Colposcopy rate
    • Performance indicator 13: Time to colposcopy
    • Performance indicator 14: Biopsy rate
    • Performance indicator 15: Yield of high-grade abnormalities on biopsy among women who attend colposcopy after higher risk scree
    • Performance indicator 16: Positive predictive value of colposcopy
  • 3.4 Diagnosis
    • Performance indicator 17a: High-grade cervical abnormality detection rate
    • Performance indicator 17b: Cervical cancer detection rate
  • 3.5 Outcomes
    • Performance indicator 18: Cervical cancers diagnosed by time since last screen
    • Performance indicator 19: Incidence of cervical cancer
    • Performance indicator 20: Mortality from cervical cancer
  • Appendix A: Additional data tables
    • A1 Participation
    • A2 Response to invitation
    • A3 Rescreening
    • A4 Screening results
    • A6 Screening HPV test positivity
    • A11 Follow up results
    • A19 Cervical cancer incidence
    • A20 Cervical cancer mortality
  • Appendix B: HPV vaccination coverage
  • Acknowledgments
  • Abbreviations
  • Symbols
  • Glossary
  • References
  • List of tables
  • List of figures
  • List of boxes
  • Related publications
  • Supplementary online data tables